Master Small Cap Index Series
Quantitative Master Series LLC
Fund classification
Classified from what the fund holds · as of 2026 Q2
Master Small Cap Index Series is a U.S. equity index fund. 29% of Master Small Cap Index Series’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 85% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Index (passive)
- Fund type
- Open-end fund
- Features
- Master-feeder
Fund profile
This fund files no prospectus profile. Unit investment trusts and closed-end funds register on forms that carry no objective or fee tagging, and some fund families file without it — a gap in what was filed, not a fund without an objective or without fees.
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 98.77% |
| Cash & short-term | 10.28% |
| Derivatives | 0.88% |
| Other | 0.00% |
Look-through blends 1 underlying fund; 0.012% of NAV was not looked through and stays direct-classified.
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Health Care | 17.5% |
| Financials | 15.8% |
| Industrials | 13.3% |
| Information Technology | 12.5% |
| 11 smaller | 40.8% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| — | BlackRock Funds III | 10.26% | — | $613.29M | — |
| MOG/A | Moog IncMOG/A | 0.38% | $423.84 | $22.39M | 52.8K |
| HUT | Hut 8 CorpHUT | 0.37% | $115.44 | $22.00M | 190.5K |
| VSAT | Viasat IncVSAT | 0.35% | $89.81 | $21.04M | 234.3K |
| BTSG | BrightSpring Health Services IncBTSG | 0.35% | $69.74 | $20.99M | 300.9K |
| CYTK | Cytokinetics IncCYTK | 0.35% | $85.19 | $20.77M | 243.9K |
| MXL | MaxLinear IncMXL | 0.34% | $128.03 | $20.45M | 159.8K |
| AGX | Argan IncAGX | 0.34% | $798.55 | $20.24M | 25.3K |
| UMBF | UMB Financial CorpUMBF | 0.33% | $142.76 | $19.45M | 136.2K |
| — | JFrog Ltd | 0.31% | $90.88 | $18.30M | 201.3K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 13.37% of net assets, top 25 17.48%, across 2.0K issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free